Alx Oncology Holdings (ALXO) Change in Account Payables (2019 - 2026)

Alx Oncology Holdings has reported Change in Account Payables for 8 years, with the latest figure at -$1.2 million in Q1 2026.

• Quarterly Change in Account Payables fell 117.63% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$233000.0 (up 89.66% YoY) and the FY2025 annual result came in at $421000.0, up 110.46% from the prior year.
• Change in Account Payables climbed to -$1.2 million in Q1 2026 per ALXO's latest filing, from -$1.7 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $8.9 million in Q3 2023 and troughed at -$5.7 million in Q2 2023.
• A 5-year average of $8882.4 and a median of -$194000.0 in 2024 frame the typical range for Change in Account Payables.
• The sharpest annual moves came in 2023 and 2025: Change in Account Payables tumbled 282.72% in 2023, then jumped 966.49% in 2025.
• Over 5 years, Change in Account Payables stood at $2.5 million in 2022, then sank by 282.72% to -$4.5 million in 2023, then grew by 24.46% to -$3.4 million in 2024, then surged by 50.72% to -$1.7 million in 2025, then increased by 27.5% to -$1.2 million in 2026.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$1.2 million, -$1.7 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.